Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study-Reference-Cited by-同舟云学术

Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study

Published:2024-09-11 Issue: Volume: Page:
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Keluth Chavan Akash¹^ORCID,Jha Pankhuri¹,Perez Jaime Abraham²,Harper Elleson²,Sinh Preetika³^ORCID,Cooper Gregory⁴,Katz Jeffry⁴,Cominelli Fabio⁵^ORCID,Regueiro Miguel⁶^ORCID,Mansoor Emad⁵

Affiliation:

1. Department of Internal Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center , Cleveland, OH , USA

2. Center for Clinical Research, University Hospitals Cleveland Medical Center , Cleveland, OH , USA

3. Division of Gastroenterology and Hepatology, Medical College of Wisconsin , Milwaukee, WI , USA

4. Digestive Health Institute, Case Western Reserve University/University Hospitals Cleveland Medical Center , Cleveland, OH , USA

5. Case Western Reserve University/University Hospitals Cleveland Medical Center/Louis Stokes Cleveland VA Medical Center , Cleveland, OH , USA

6. Department of Gastroenterology, Hepatology, and Nutrition, Digestive Disease and Surgery Institute, Cleveland Clinic Foundation , Cleveland, OH , USA

Abstract

Lay Summary Tumor necrosis factor (TNF) inhibitor therapy for inflammatory bowel disease (IBD) has been associated with an increased risk of rheumatoid arthritis and other inflammatory conditions. Our retrospective study did not show an increased risk when compared with non-anti-TNF therapy for IBD.

Funder

Clinical and Translational Science Collaborative of Northern Ohio

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izae203/59087555/izae203.pdf

Reference10 articles.

1. Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview;Toussirot;RMD Open,2016

2. Tumor necrosis factor inhibitors in inflammatory bowel disease and risk of immune mediated inflammatory diseases;Ward;Clin Gastroenterol Hepatol.,2024

3. Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents;Fiorino;Autoimmun Rev.,2014

4. Paradoxical reactions to biologicals in chronic inflammatory systemic diseases;Kremenevski;Dtsch Arztebl Int,2022

5. Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis;Alivernini;RMD Open,2018